ISOIB
The aim of the Conference is to provide a platform to the researchers and practitioners from both academia as well as industry to meet the share cuttingedge development in the field.
ISOIB
The aim of the Conference is to provide a platform to the researchers and practitioners from both academia as well as industry to meet the share cuttingedge development in the field.
Oncology
Immunotherapy
Biomarkers
Cancer Research
Cancer Biology
Tumor Biology
Precision Medicine
Cancer Treatment
Translational Oncology
Health Policy
Start Date
Thursday, May 28, 2026
Registration Deadline
Wednesday, May 13, 2026
Submission Deadline
Friday, May 8, 2026
Washington DC, Washington, United States